Outcomes of Endovascular Treatment for Posterior Circulation Stroke According to the Underlying Pathologic Mechanism: A Retrospective Single-Center Analysis
Table 3
Outcome analyses of basilar artery occlusion between embolism group and intrinsic group.
All patients ()
Embolism group ()
Intrinsic group ()
Unadjusted analysis
Adjusted analysis
OR (95% CI)
value
OR (95% CI)
value
mTICI 2b-3
80 (92.0)
44 (95.7)
36 (87.8)
3.05 (0.55-16.69)
0.24
0.84 (0.01-55.12)
0.93
Symptomatic ICH
5 (5.7)
4 (8.7)
1 (2.4)
3.81 (0.40-35.55)
0.36
∞(0.00-∞)
0.09
Functional outcome at 90 days
Favorable (mRS 0-2)
29 (33.3)
18 (39.1)
11 (26.8)
1.75 (0.70-4.35)
0.26
2.09 (0.44-9.83)
0.34
Moderate (mRS 0-3)
40 (46.0)
19 (41.3)
21 (51.2)
0.67 (0.28-1.56)
0.39
0.60 (0.13-2.65)
0.50
Mortality (mRS 6)
28 (32.2)
16 (34.8)
12 (29.3)
1.28 (0.52-3.18)
0.65
2.03 (0.39-10.57)
0.39
Adjusted for age, atrial fibrillation, hypertension, anticoagulant, fast glucose, Pc-ASPECTS, onset to recanalization, aspiration, stent angioplasty, balloon angioplasty, and IA and/or IV tirofiban. ICH: intracranial hemorrhage; mRS: modified Rankin Score; mTICI: modified Tissue Thrombolysis in Cerebral Ischemia; OR: odds ratio.
